Home › Therapeutic areas › GI/Hepatology › Celiac Disease
Celiac Disease (3 companies)
Companies with an active program in Celiac Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ANAB | AnaptysBio | DermatologyGI/Hepatology+2 Rare | 1 | Approved | $1.39B | 9 |
| FBRX | Forte Biosciences | DermatologyGI/Hepatology | 1 | Phase 2 | — | 3 |
| IMUX | Immunic | GI/HepatologyNeurology | 1 | Phase 3 | $106M | 4 |
No companies match.